Delivery Order SPE2DR25D1100-SPE2DR26FCP3C
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) valued at $4,372.26 under a firm fixed-price contract type. The award was made on September 18, 2025, with an ultimate completion date of September 19, 2025, and the work will be performed in Conshohocken, Pennsylvania. This delivery order represents a non-set-aside, competitively awarded transaction and is part of AmerisourceBergen's broader relationship with the...
- The Defense Logistics Agency awarded a delivery order valued at $1,293.20 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count), with an ultimate completion date of November 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the prime contractor. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) with a ceiling value of $2,305.86. This firm fixed-price delivery order, issued on July 24, 2025, with an ultimate completion date of July 25, 2025, represents a competitively awarded contract with no set-aside designation. The award supports pharmaceutical supply to federal military and healthcare systems, with performance based in Conshohocken, Pennsylvania,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100 count) valued at $2,707.18, with a firm fixed price structure and completion deadline of August 4, 2025. This non-set-aside award, issued on August 1, 2025, represents a single delivery order under the company's existing contract vehicle with DLA. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units. The contract is valued at $3,667.68 with a firm fixed-price structure and is scheduled for completion by August 6, 2025. This competitively awarded delivery order carries no set-aside designation and will be fulfilled at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a...
- The Defense Logistics Agency awarded a delivery order valued at $1,456.01 to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100s) on July 24, 2025, with completion scheduled for July 25, 2025. This competitively awarded, firm fixed price delivery order was issued without set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting federal medical supply...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 10 mg tablets (100-count units) valued at $1,052.59, with an ultimate completion date of August 26, 2025. This competitive, non-set-aside contract was awarded on a firm fixed-price basis under a delivery order contract type. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of OxyContin ER 20 mg tablets (100 count) valued at $10,845.48 under a firm fixed-price contract. The award, issued on September 24, 2025, with an ultimate completion date of September 25, 2025, was made without a set-aside designation through competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal...
- The Defense Logistics Agency awarded a $8,292.15 delivery order to AmerisourceBergen Drug Corp for OxyContin ER 40 mg tablets (100-count units) on September 15, 2025, with an ultimate completion date of September 16, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child delivery order under AmerisourceBergen's broader pharmaceutical supply agreements. The product will be delivered to the company's Conshohocken, Pennsylvania facility, which serves as the prime...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of OxyContin ER 20 mg tablets in quantities of 100 units. This contract is valued at $2,284.62 under a firm fixed-price delivery order arrangement with no set-aside designation, indicating the award was made through open competition. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCP3CDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for OxyContin ER 20 mg tablets (100-count units) valued at $1,946.92, with an ultimate completion date of November 17, 2025. This non-set-aside, firm fixed-price delivery order was competitively awarded on November 14, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The award represents a single transaction under AmerisourceBergen's broader federal pharmaceutical supply agreement with the agency. This delivery order is issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion global pharmaceutical support vehicle valued through December 2026. As a major pharmaceutical distributor and critical federal medical procurement vendor, AmerisourceBergen supplies an extensive portfolio of medications, vaccines, medical devices, and healthcare commodities to support military and veteran healthcare systems. The company's contract portfolio with DLA demonstrates consistent capability to fulfill federal medical supply requirements across multiple therapeutic domains through competitive open-market awards.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 11/14/25 |